Flexibility in Mannan-Binding Lectin-Associated Serine Proteases-1 and -2 Provides Insight on Lectin Pathway Activation by Nan, R et al.
ArticleFlexibility in Mannan-Binding Lectin-Associated
Serine Proteases-1 and -2 Provides Insight on Lectin
Pathway ActivationHighlightsd Ca2+-bound MASP crystal structures reveal binding sites for
MBL and other ligands
d The MASP crystal structures predict linear domain structures
d Solution structures of MASP-1 and MASP-2 are bent by as
much as 90 from linearity
d Flexibility in MASP dimers may permit both intra- and inter-
complex activationNan et al., 2017, Structure 25, 1–12
February 7, 2017 ª 2017 The Authors. Published by Elsevier Ltd
http://dx.doi.org/10.1016/j.str.2016.12.014Authors
Ruodan Nan (南若丹),
Christopher M. Furze, DavidW.Wright,
Jayesh Gor, Russell Wallis,
Stephen J. Perkins
Correspondence
s.perkins@ucl.ac.uk
In Brief
Nan et al. show that MASPs, the serine
proteases responsible for initiating the
lectin pathway of complement activation,
are much more flexible in solution than
previously thought. This flexibility
probably facilitates both intra- and inter-
complex activation when mannan-
binding lectin-MASP complexes bind to
pathogen surfaces..
Please cite this article in press as: Nan et al., Flexibility in Mannan-Binding Lectin-Associated Serine Proteases-1 and -2 Provides Insight on Lectin
Pathway Activation, Structure (2017), http://dx.doi.org/10.1016/j.str.2016.12.014Structure
ArticleFlexibility in Mannan-Binding Lectin-Associated
Serine Proteases-1 and -2 Provides Insight
on Lectin Pathway Activation
Ruodan Nan (南若丹),1 Christopher M. Furze,2 David W. Wright,1 Jayesh Gor,1 Russell Wallis,2 and Stephen J. Perkins1,3,*
1Department of Structural andMolecular Biology, Division of Biosciences, University College London, Darwin Building, Gower Street, London
WC1E 6BT, UK
2Departments of Infection, Immunity and Inflammation and Molecular Cell Biology, University of Leicester, University Road, Leicester, LE1
9HN, UK
3Lead Contact
*Correspondence: s.perkins@ucl.ac.uk
http://dx.doi.org/10.1016/j.str.2016.12.014SUMMARY
The lectin pathway of complement is activated by
complexes comprising a recognition component
(mannose-binding lectin, serum ficolins, collectin-
LK or collectin-K1) and a serine protease (MASP-1
or MASP-2). MASP-1 activates MASP-2, and
MASP-2 cleaves C4 and C4b-bound C2. To clarify
activation, new crystal structures of Ca2+-bound
MASP dimers were determined, together with their
solution structures from X-ray scattering, analytical
ultracentrifugation, and atomistic modeling. Solution
structures of the CUB1-EGF-CUB2 dimer of each
MASP indicate that the two CUB2 domains were
tilted by as much as 90 compared with the crystal
structures, indicating considerable flexibility at the
EGF-CUB2 junction. Solution structures of the full-
length MASP dimers in their zymogen and activated
forms revealed similar structures that were much
more bent than anticipated from crystal structures.
We conclude that MASP-1 and MASP-2 are flexible
at multiple sites and that this flexibility may permit
both intra- and inter-complex activation.
INTRODUCTION
Complement destroys invading microorganisms and initiates
defense mechanisms including chemotaxis, phagocytosis, cell
adhesion, B cell differentiation, and maintenance of immune
tolerance (Carroll, 2004; Porter and Reid, 1978). It also facilitates
tissue remodeling, homeostasis, and resolution of inflammation
via apoptosis and clearance of cellular debris (Botto, 1998; Tay-
lor et al., 2000). Defects in complement are associated with im-
munodeficiencies, autoimmune diseases, tissue damage,
anaphylaxis, transplant rejection, and necrosis. Complement
via the lectin pathway is initiated when mannan-binding lectin
(MBL), serum ficolins, collectin-KL, and/or collectin-K1 bind to
pathogens and activate MBL-associated serine proteases
(MASP-1 and MASP-2 and MASP-3) (Figure 1). The importanceStructure 25, 1–12,
This is an open access article undof the lectin pathway is highlighted by common immunodefi-
ciencies associated with mutations to MBL (Turner, 1996) and
MASP-2 (Stengaard-Pedersen et al., 2003). Inappropriate lectin
pathway activation causes tissue damage following transient
ischemia (Schwaeble et al., 2011), so modulators of the lectin
pathway are likely to have important therapeutic benefits.
MBLs are large oligomers (150–300 kDa), predominantly
dimers to tetramers of a homotrimeric subunit (Wallis and Drick-
amer, 1999). In each homotrimer, pathogen recognition is medi-
ated through the coordinated binding of three globular carbohy-
drate recognition domains (CRDs) connected to a rod-like
collagenous stem (Figure 1). MASPs are homodimers that circu-
late as zymogens bound to the collagenous domains of MBL
(Wallis and Dodd, 2000). Each MASP comprises two N-terminal
CUB (C1r/C1s, Uegf, and bone morphogenetic protein-1) do-
mains separated by an epidermal growth factor (EGF)-like
domain followed by two short complement regulator (SCR) do-
mains and a C-terminal serine protease (SP) domain (Figure 1).
MASP-1 and MASP-3 are alternatively spliced products from
the same gene. Activation occurs following cleavage at a single
site between the SCR2 and SP domains when MBLs bind to a
pathogen surface. MASP-1 cleaves MASP-2, which subse-
quently cleaves the downstream complement components C4
and C4-bound C2 to form the C3 convertase (Wallis et al.,
2007). MASP-1 and/or MASP-3 facilitate activation of the alter-
native pathway through activation of factors D and B (Iwaki
et al., 2011; Takahashi et al., 2010). It is often assumed that
the MBLs adopt bouquet-like structures similar to complement
C1q. Instead, our recent atomistic scattering modeling showed
that they have near-planar, fan-shaped structures in solution
(Figure 1), which raises new questions on how the complexes
activate complement (Miller et al., 2012). In two different theories
following attachment of the MBL-MASP complex to a patho-
genic surface, either (1) each monomer within the MASP dimer
is able to bend significantly to enable one SP domain to activate
its partner, as occurs for the MASP homologs, C1r and C1s
within the C1 complex, or (2) a given MASP-MBL complex acti-
vates neighboring MASP molecules on adjacent MBL-MASP
complexes (Degn et al., 2014; Wallis et al., 2010). A recent anal-
ysis by small- angle X-ray scattering (SAXS) and electron micro-
scopy (EM) favored the inter-complex model, concluding that
MASP-1 was only modestly flexible and the protease domainsFebruary 7, 2017 ª 2017 The Authors. Published by Elsevier Ltd. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Domain Organization of MASP and Its MASP-MBL
Complex
Each MASP monomer is composed of six domains. An MBL monomer is a
homotrimer of three polypeptides, each forming an N-terminal cysteine-rich
region, a collagen-like region, an a-helical neck region, and a C-terminal car-
bohydrate recognition domain (CRD). An interruption (‘‘kink’’) may induce
flexibility in the collagen region. A schematic MBL tetramer is shown bound to
an MASP dimer at two CUB1 domains. The MASP sequences are colored
according to the MASP domains. Glycosylation sites are shown in black,
together with expression tags and linkers.
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Here, we investigate the dimer structures of MASP-1 and
MASP-2 through the combination of SAXS, analytical ultracentri-
fugation (AUC), and a new atomistic modeling procedure (Per-
kins et al., 2011, 2016). While several crystal structures are
known for the N-terminal MASP fragments (Feinberg et al.,2 Structure 25, 1–12, February 7, 20172003; Gingras et al., 2011; Gregory et al., 2004; Skjoedt et al.,
2012; Teillet et al., 2006) and for the C-terminal MASP fragments
(Dobo et al., 2009; Gal et al., 2005; Harmat et al., 2004; Heja
et al., 2012; Kidmose et al., 2012), these are incomplete. In
particular, MASP-2 CUB1-EGF-CUB2 (subsequently called
MASP-2 3D) was crystallized in the presence of citrate that che-
lates Ca2+, and although Ca2+ was bound to the EGF-like
domain, the CUB1 and CUB2 domains lacked Ca2+ and became
partially disordered as a result (Feinberg et al., 2003). Here, to
complete our knowledge of the MASP structures, we first
applied X-ray crystallography to the N-terminal fragments to
identify the importance of bound Ca2+. Next, by applying our
strategy to the zymogen and activated forms of MASP, we as-
sessed whether the MASP dimer is sufficiently flexible to allow
auto-activation or inter-molecular activation.
There are four potential binding sites for MBL stems on each
MASP homodimer—one on each of the four CUB domains
(Wallis and Dodd, 2000; Figure 1). The crystal structures of
collagen-like peptides bound to CUB1 and CUB2 mean we
now know the MBL-MASP contacts at atomic resolution (Ging-
ras et al., 2011; VenkatramanGirija et al., 2013). These structures
reveal key contacts between an essential Lys46 residue in the
collagen-like region of MBL and three Ca2+-binding residues in
CUB2. The Ca2+-binding site is conserved in CUB1, which binds
to a separate collagen stem. By comparing the MASP solution
structures with models for MBL, we evaluated the MASP-MBL
complexes that trigger complement activation. In particular,
our new MASP structures clarify the extent to which the MASPs
undergo significant conformational changes during activation af-
ter pathogen binding by MBL.
RESULTS
Purification and Crystal Structure Determination
of MASPs
Following the crystallography and scattering strategy used for
rat MBL (Miller et al., 2012), we expressed full-length rat
MASP-1 and MASP-2 zymogens and both their 3D fragments
for structural analysis (Figure 1). Repeated attempts to obtain dif-
fracting crystals of full-length MASP-1 andMASP-2 were unsuc-
cessful, probably due to inter-domain flexibility. An alternative
strategy involving crystallography of MASP fragments was fol-
lowed. Because there was no structure of rat MASP-1 3D, and
the existing structure of rat MASP-2 3D lacked two of the three
Ca2+, including those Ca2+ that form part of the binding site for
MBL, both rat MASP-1 3D and MASP-2 3D were crystallized in
the presence of 2 mM calcium and diffraction data were
collected. This resulted in one MASP-1 structure at 3.7 A˚ resolu-
tion and three independent MASP-2 structures at 2.6–2.7 A˚ res-
olution (Table 1).
The four electron densitymapswere of high quality (Figure S1).
For MASP-1 3D, 276 of its 281 residues could be built into the
electron density map. The resulting structure was similar to the
corresponding structure of human MASP-1 (PDB: 3DEM), with
a root-mean-square deviation (RMSD) of 0.961 A˚ over 267 resi-
dues (Teillet et al., 2008). For MASP-2 3D, 279 of 280 residues
were visible. Interestingly, the three structures overlaid closely,
with RMSDs of 0.682, 0.871, and 0.992 A˚ over 276 Ca atoms.
The only notable differences were in the N-terminal seven
Table 1. Crystallographic Data Collection and Refinement Statistics for Rat MASP-2 3D and MASP-1 3D
MASP-2 MPD/Acetate MASP-2 PEG 20K MASP-2 MPD/Citrate MASP-1
Data Collection
Beamline Diamond I04-1 Diamond I04-1 Cu2+ home source Diamond I04
Space group P 21 21 21 C 2 2 21 C 2 2 21 I 2 3
a, b, c (A˚) 83.6, 91.3, 127.1 66.9, 98.3, 121.4 82.9, 119.4, 104.0 152.7, 152.7, 152.7
a, b, g,  90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90
Resolution (A˚) 63.6–2.6 (2.69–2.60) 50.3–2.58 (2.60–2.58) 22.9–2.73 (2.82–2.73) 76.4–3.70 (4.14–3.70)
Rsym 0.082 (0.321) 0.099 (0.645) 0.167 (0.653) 0.082 (0.743)
I/s(I) 16.04 (2.10) 11.55 (2.03) 6.4 (1.53) 9.2 (1.51)
Completeness 97.6 (98.8) 97.6 (93.5) 99.4 (94.4) 99.9 (99.9)
Redundancy 5.0 (5.2) 3.9 (3.6) 2.0 (2.0) 5.6 (5.5)
Refinement
Resolution (A˚) 63.55–2.6 (2.69–2.60) 50.34–2.58 (2.67–2.58) 22.9–2.73 (2.82–2.73) 76.4–3.70 (3.84–3.70)
No. of reflections 29,893 (2,998) 12,626 (1,195) 14,031 (1,319) 6,473 (1827)
Rwork/Rfree 0.205/0.254 0.207/0.245 0.204/0.266 0.248/0.294
No. of atoms 4,502 2,303 2,369 2,271
Protein 4,433 2,208 2,211 2,239
Ligand/ion 6 17 17 32
Water 63 78 141 –
B factors (A˚2) 93.40 51.60 34.70 187.20
Protein 93.90 51.70 35.00 187.60
Ligand/ion 65.80 78.20 65.90 155.50
Water 62.30 44.30 26.80 –
PDB 5CKN 5CIS 5CKM 5CKQ
RMSDs
Bond lengths (A˚) 0.004 0.003 0.004 0.002
Bond angles () 1.01 0.72 0.82 0.75
Ramachandran (%)
Favored 94 93 94 92
Allowed 6 7 6 8
Disallowed 0 0 0 0
The buffers are defined in full in the Supplemental Information. The highest resolution shell is shown in parentheses.
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Ser130), probably reflecting flexibility. All three MASP-2 3D
structures were similar to the previous structure of rat MASP-2
3D (PDB: 1NT0) with RMSDs of 1.20, 1.35, and 1.57 A˚ over
257 Ca atoms (Feinberg et al., 2003). A major difference, how-
ever, was that the structures now contained three bound Ca2+
compared with the single Ca2+ in the EGF-like domain of the
earlier MASP-2 3D structure. Each CUB domain bound one
Ca2+, where the Ca2+-binding residues and binding loops were
well defined. These Ca2+ sites are functionally important
because they orientate and form the binding site for MBL, fico-
lins, CL-KL, and CL-K1 (Gingras et al., 2011). All four crystal
structures revealed a dimer of MASP-1 3D or MASP-2 3D,
formed by antiparallel neighboring contacts between pairs of
CUB1-EGF domains about the crystallographic symmetry axis
(Figures 2A and 2B). The same dimer was seen in earlier crystal
structures of MASPs (PDB: 1NT0 and 3DEM), further supporting
earlier conclusions that this is physiologically relevant (Feinberg
et al., 2003; Gregory et al., 2003; Skjoedt et al., 2012; Teillet et al.,
2008). The total buried surface area for MASP-1 at the dimerinterface was 880 A˚2 per molecule (1,760 A˚2 in total), whereas
the three crystal structures for MASP-2 gave 1,200, 1,090, and
950 A˚2 per molecule. These values were in excess of 800 A˚2,
consistent with stable dimer formation (Rupp, 2010).
Bioavailable calcium is typically present in plasma at around
2.5 mM (Hurwitz, 1996). All four new crystal structures revealed
well-ordered, similar calcium-binding sites in each of the CUB1
and CUB2 domains (Figures 2A and 2B). These were previously
seen for human MASP-1 3D, but not for rat MASP-2 3D (Figures
2C and 2D). In the MASP-1 CUB1 domain, Ca2+ formed contacts
with six oxygen atoms in the side chains of Glu49, Asp57,
Asp102, Ser104, and Asn105 (distances between 2.3 and
2.4 A˚). In the MASP-2 CUB1 domain, Ca2+ formed contacts
with six oxygen atoms in the side chains of Glu48, Asp56,
Asp101, and Asn104 and the main chain oxygen of Ser103 (dis-
tances between 2.3 and 2.7 A˚; Figure S1A). In theMASP-1 CUB2
domain, Ca2+ now formed contacts with five oxygen atoms in the
structurally equivalent side chains of Glu216, Asp226, Asp263,
and Ser265. In theMASP-2CUB2 domain, Ca2+ formed contacts
with five oxygen atoms at the side chains of Glu215, Asp225,Structure 25, 1–12, February 7, 2017 3
Figure 2. Crystal Structures of MASP-1 and MASP-2 3D Dimers and
Their Ca2+-Binding Sites
(A) MASP-1 3D is shown in face-on and side-on views, related by a 90 rota-
tion. Ca2+ are shown as yellow spheres.
(B) The three structures for MASP-2 3D are in blue, green, and cyan, also
shown in face-on and side-on views.
(C) The rat MASP-1 3D structure (red) is superimposed upon its human
equivalent (gray; PDB: 3DEM). All three Ca2+ are visible in both structures, with
the Ca2+-binding residues shown in red.
(D) The rat MASP-2 3D structure (blue) is superimposed upon its rat equivalent
from 2003 (gray; PDB: 1NT0). All three Ca2+ are now visible in the new struc-
ture, again with Ca2+-binding residues shown in red.
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that in CUB1 only by the omission of the side chain with the
structurally equivalent Asn105/Asn104 oxygen atom in CUB2.4 Structure 25, 1–12, February 7, 2017Nonetheless, this Ca2+ site was similar to that reported in the
CUB2 domain of MASP-1 alone (Gingras et al., 2011). Compar-
ison of the same CUB1/CUB2 region in the earlier crystal struc-
ture of rat MASP-2 showed disorganized binding loops in the
absence of calcium (Figure 2D), suggesting that Ca2+ stabilizes
the MBL-binding residues. The EGF domains of MASP-1 and
MASP-2 also bound calcium (Figures 2C and 2D).
X-Ray Scattering of Rat MASPs
X-ray scattering measures by diffraction the overall structure of
biological molecules in randomized orientations in solution (Per-
kins et al., 2011). Here, solution scattering identified the domain
structures of MASP-1 3D, MASP-2 3D, MASP-1 zymogen/acti-
vated, and MASP-2 zymogen/activated, with and without Ca2+,
in order to verify the structures seen by crystallography. The
scattering data I(Q) were collected at concentrations dilute
enough to minimize concentration effects (0.25–1.36 mg/mL).
The MASPs showed no radiation damage or X-ray induced ag-
gregation in the time frame analyses. The time-averaged runs
were thus used for data analyses. Guinier analyses of the I(Q)
data in two separate Q ranges gave the radius of gyration Rg
and the cross-sectional radius of gyration Rxs (Figure 3).
The Rg value monitors the overall degree of elongation of the
MASP dimers. At the lowest Q values, the Rg values were
measured within satisfactory Q.Rg limits in concentration series
between 0.25 and 1.26mg/mL for the sixMASPs (Figure 3A). The
mean of two to four Rg values were 3.83 ± 0.02 nm for MASP 3D
and 7.73 ± 0.20 nm for full-length MASP (Table 2). The Rg values
for the full-length MASPs were almost double those of the MASP
3Ds, this being as expected if the full-length MASPs have
extended six-domain structures. No change with protein con-
centrations in either the I(0)/c or Rg values for each of the six
MASPs was observed. This meant that no self-association or
conformational change in MASP was detectable with change
in protein concentration. No change between the pairs of Rg
values for zymogen and activated MASP-1 and MASP-2 was
seen (Table 2), indicating that their domain arrangements were
unaffected by cleavage of the SCR2-SP linker.
The cross-sectional Rxs Guinier analyses monitored the
shorter dimensions of the MASP dimers. The ln I(Q).Q versus
Q2 plots showed linear regions in the 3D and full-length proteins
(Figure 3B), indicating that both proteins were elongated. The re-
sultingRxs values for MASP-1 3D andMASP-2 3Dwere similar at
1.94 ± 0.01 nm and 1.74 ± 0.02 nm, respectively (Table 2). For the
full-length zymogen and activated MASP, the four I(Q).Q versus
Q2 plots showed inflexions before a linear Rxs region, indicating
complex but similar domain arrangements in MASPs. The result-
ing Rxs values were indistinguishable for zymogen and activated
MASP-1 (at 1.53–1.54 nm) and MASP-2 (both at 1.46 nm). This
indicated no major conformational differences between the
zymogen and activated forms, even with the addition or removal
of Ca2+. The similar Rxs values for MASP-1 and MASP-2 indi-
cated that both showed similar cross-sectional structures.
The distance distribution function P(r) represented all the dis-
tances between pairs of atoms within the macromolecule. This
provided structural information in real space. The P(r) curve pro-
vided an alternative calculation of the Guinier Rg value and gave
maximum lengths (L) following an assumption of the maximum
dimension (Dmax). The Rg values from P(r) were similar to those
Figure 3. SAXS Guinier and P(r) Analyses
The upper three rows correspond to MASP-1 with
Ca2+. The bottom three rows correspond to
MASP-2 with (gray) and without Ca2+ (black). The
Rg, Rxs, and P(r) analyses for each protein are
shown.
(A and B) Open circles correspond to data points,
and filled circles correspond to those used for the
Guinier Rg and Rxs values. The Q ranges for the Rg
and Rxs fits are arrowed (Supplemental Informa-
tion).
(C) The P(r) curves were normalized to 100 for
clarity. The maximum length of each molecule is
denoted by L at the r values where the P(r) curves
reach 0. The peak maximaM for the MASP 3D and
M1 andM2 forMASP-1 andMASP-2 represent the
most frequent distances within their structures.
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length L of the MASPs was determined from the r value when
P(r) = 0 at large r (Figure 4C). For both 3D MASPs, a single
peak was observed in P(r) with the most common intra-particle
distance at a maximum M of 3.9 nm and a length L of 13 nm.
This M value corresponds well to the mean intra-domain dis-
tance within the four CUB domains. For zymogen and activated
full-length MASP, two peaksM1 andM2 at 3.4 nm and 10.7 nm,
respectively, were seen.M1was assigned to structures similar to
those in MASP 3D. M2 corresponded well to the distances be-
tween the two SP domains and the CUB domains in the center
of the MASP dimer.
Analytical Ultracentrifugation of Rat MASPs
AUC studies solution structures by monitoring their sedimenta-
tion under high centrifugal force (Cole et al., 2008). This provided
information on the structure and oligomerization of MASP. The
latter was important because the MASPs were purified in low
20 mM NaCl salt, which may promote oligomer formation. Sedi-
mentation velocity experiments were performed on the six
MASPs at concentrations similar to those used for SAXS in phys-
iological ionic strength conditions in the same buffers with Ca2+
or EDTA (Figures 4A and 4E). The velocity data were analyzed
using absorbance optics to generate the size distribution ana-
lyses c(s). The analyses of up to 80 boundaries revealed excel-
lent fits and satisfactory RMSDs. The mass determination fromthe single c(s) peak showed that all six
samples were dimers with no detectable
monomer or higher oligomer (Figures
4B–4D and 4F–4H). The molecular mass
of MASP-1 3D was 74 ± 2 kDa, and that
for MASP-2 3D was 65 ± 2 kDa, in good
agreement with sequence-calculated
masses of 75 kDa for MASP-1 3D and
74 kDa for MASP-2 3D. That for zymogen
MASP-1 was 163 ± 6 kDa, activated
MASP-1 was 158 ± 6 kDa, zymogen
MASP-2 was 147 ± 6 kDa, and activated
MASP-2 was 166 ± 1 kDa. These values
agreed well with the sequence-predicted
masses of 170 kDa and 163 kDa for full-lengthMASP-1 andMASP-2 dimers, respectively. The sedimen-
tation coefficient s20,w provided an independent measure of
macromolecular elongation. The s20,w values of MASP-1 3D
and MASP-2 3D were 4.53 S and 4.09 S, respectively (Table
2). The s20,w values of zymogen and activated MASP-1 were
5.90 S and 5.79 S, respectively, and those for zymogen and acti-
vated MASP-2 were 5.42 S and 5.62 S, respectively (Table 2).
The s20,w value for MASP-2 3D was similar to that of 4.55 ±
0.10 S reported previously (Feinberg et al., 2003).
The availability of initial models or structures for MASP
permitted comparison of the experimental s20,w values with
those predicted from these. The precision of the comparisons
is ±0.21 S (Perkins et al., 2016). Interestingly, the prediction of
4.26 S from the MASP-1 3D crystal structure was similar to
the observed value of 4.53 ± 0.08, while that of 4.18 S from
the MASP-2 crystal structure was close to the observed value
of 4.09 ± 0.07 S (Table 2). The solution structures of both pro-
teins thus broadly resembled those seen by crystallography
(Figures 2A and 2B). In distinction, for the zymogen and acti-
vated forms of MASP-1 and MASP-2, these comparisons
showed deviations from the initial models. For the full-length
MASPs, the initial predictions of 5.38 S, 5.50 S, 5.28 S, and
5.28 S (Figures 4C, 4D, 4G, and 4H) were lower than the
observed values of 5.90 ± 0.15 S, 5.79 ± 0.13 S, 5.42 ± 0.15
S, and 5.62 ± 0.16 S, respectively (Table 2), indicating that the
solution structures were more bent than the initial extendedStructure 25, 1–12, February 7, 2017 5
Table 2. Experimental and Modeled X-Ray Scattering and
Sedimentation Coefficient Data
Rg (nm)
a Rxs (nm) L (nm) s20,w (S)
b
Experimental
MASP-1 3D
(12 curves)
3.79 ± 0.01
3.97 ± 0.01
1.94 ± 0.01 13 4.53 ± 0.08
MASP-2 3D
(9 curves)
3.87 ± 0.02
3.99 ± 0.01
1.74 ± 0.02 12 4.09 ± 0.07
Zymogen
MASP-1
(14 curves)
7.93 ± 0.09
8.23 ± 0.02
1.54 ± 0.02 26 5.90 ± 0.15
Activated
MASP-1
(8 curves)
7.86 ± 0.12
8.22 ± 0.02
1.53 ± 0.02 26 5.79 ± 0.13
Zymogen
MASP-2
(9 curves)
7.58 ± 0.13
7.98 ± 0.02
1.46 ± 0.06 27 5.42 ± 0.15
Activated
MASP-2
(4 curves)
7.54 ± 0.04
7.79 ± 0.04
1.46 ± 0.05 26 5.62 ± 0.16
Best-Fit Models
MASP-1 3D 3.79 ± 0.09 1.93 ± 0.03 14.1 ± 0.7 4.25 ± 0.07
MASP-2 3D 3.92 ± 0.07 1.89 ± 0.33 14.3 ± 0.5 3.96 ± 0.03
Zymogen
MASP-1
7.73 ± 0.17 1.71 ± 0.06 26.4 ± 0.9 5.92 ± 0.05
Activated
MASP-1
8.09 ± 0.23 1.67 ± 0.10 25.1 ± 1.2 5.92 ± 0.07
Zymogen
MASP-2
7.34 ± 0.27 1.32 ± 0.22 23.5 ± 1.0 5.69 ± 0.10
Activated
MASP-2
7.70 ± 0.18 1.49 ± 0.10 25.3 ± 1.1 5.61 ± 0.10
aThe mean Rg values from the Guinier analyses are shown first, followed
by the mean Rg values from the P(r) analyses, the mean Rxs values from
the Guinier analyses, and the mean L values from the P(r) analyses
(Figure 3).
bThe mean s20,w values observed at 50,000 rpm are shown (Figure 4).
Please cite this article in press as: Nan et al., Flexibility in Mannan-Binding Lectin-Associated Serine Proteases-1 and -2 Provides Insight on Lectin
Pathway Activation, Structure (2017), http://dx.doi.org/10.1016/j.str.2016.12.014homology models. This evidence for more compact structures
indicated flexibility in the MASP-1 and MASP-2 structures that
had not been previously recognized.Atomistic Scattering Modeling of Rat MASPs
As for rat MBL (Miller et al., 2012), atomistic modeling for the six
MASPs assessed whether the two linear MASP 3D crystal struc-
tures and four linear homology models for full-length MASP
agreed with the experimental SAXS data. The predicted Rg
values of 3.62 nm and 3.58 nm from the MASP-1 3D and
MASP-2 3D crystal structures were less than but similar to the
observed Rg values of 3.79 ± 0.01 nm and 3.87 ± 0.02 nm (Table
2; Figures 5A and 5D) to indicate that their solution structures
broadly resembled their crystal structures (Figures 2A and 2B).
In contrast, the linear homology models of zymogen and acti-
vated full-length MASP-1 gave predicted Rg values of 9.00 nm
and 8.68 nm that were 10–13% greater than the observed Rg
values of 7.93 ± 0.09 nm and 7.86 ± 0.12 nm (Table 2; Figures
5B and 5C). The predicted Rg values of 8.36 nm and 8.23 nm
for the initial models of zymogen and activated full-length6 Structure 25, 1–12, February 7, 2017MASP-2 were likewise 9–10% greater than the observed Rg
values of 7.58 ± 0.13 nm and 7.54 ± 0.04 nm (Table 2; Figures
5E and 5F). These Rg differences show that the full-length pro-
teins in solution were more bent and compact in shape than
the linear initial models, in agreement with the modeling of the
s20,w values.
To identify detailed 3D solution structures, atomistic modeling
searches were performed (Perkins et al., 2016). The MASP 3D
crystal structures were used to generate physically realistic
structures. Regions of flexibility were assigned to the EGF-
CUB2 linkers and C-terminal hexaHis tags (Figure 1). The
CUB1-EGF dimer contacts did not allow flexibility at the
CUB1-EGF linker. Using a Monte Carlo procedure, the EGF-
CUB2 linker peptides were randomized to generate 1,982–
4,517 trial MASP 3D structures for computing their SAXS
curves. A large improvement in the goodness-of-fit R factor to
4.8%–7.4% was obtained, compared with 9.2%–11.2% for
the two crystal structures (Figures 5A and 5D). This decrease
showed that the use of flexible EGF-CUB2 linkers resulted in
significantly improved curve fits (Figures 6A and 6D). When
two N-glycan oligosaccharides in extended conformations
were added to the structures, the agreement between the
experimental and calculated I(Q) and P(r) curves improved to
R factors of 4.1%–4.2% (Figures 6A and 6D). All ten best-fit
structures retain this conformational feature, being bent inward
toward the center of the MASP 3D dimer (Figures 7A and 7D).
When the degree of bending was parameterized (Figure S2A),
the separation of 9.8–10.0 nm between the centers of the
CUB2 domains in the two crystal structures was almost un-
changed at 9.5 ± 0.5 nm in the ten best-fit models for MASP-1
3D and MASP-2 3D, while the angle between the two CUB2 do-
mains was significantly decreased from 171 to as low as 142 ±
8 (Table S1). As an independent check of themodeling, the pre-
dicted s20,w values from the ten best-fit models for each of
MASP-1 3D and MASP-2 3D gave mean values of 4.25 ±
0.07 S and 3.96 ± 0.03 S. These were similar to the experimental
s20,w values of 4.53 ± 0.08 S and 4.09 ± 0.07 S, as for the two
crystal structures (Figures 2A and 2B). In conclusion, while our
atomistic modeling revealed similar extended MASP 3D struc-
tures in solution and in the crystal, the final SAXS models indi-
cated large differences in the two 3D structures in which the
CUB2 domains were bent right back, as much as vertically up-
ward from the plane of the CUB1-EGF domains (Figures 6A,
6D, 7A, and 7D). Importantly for function, these differences sug-
gest that the EGF-CUB2 junction is a flexible hinge with a 90
flex (Figure S2 and Table S1).
Atomistic SAXS modeling was also performed for full-length
MASPs using the linear homology models to generate physically
realistic varied structures. Flexible regions were assigned at the
EGF-CUB2, CUB2-SCR1, SCR1-SCR2, and SCR2-SP linkers
and the N-terminal hexaHis tags. The MASP 3D crystal structure
was used in this. By aMonte Carlo procedure, the five linker pep-
tides were varied to generate 6,173–30,910 trial MASP struc-
tures. The resulting goodness-of-fit R factors versus Rg values
(Figures 5B, 5C, 5E, and 5F) showed that the linear homology
model R factor values of 7.7%–9.1% were reduced to 6.5%–
7.1% for the best-fit models. In addition, the best-fit models
showed better agreements between the experimental and
modeled Rg values. Bends in the four inter-domain linkers thus
Figure 4. Sedimentation Velocity Analyses
of the MASPs
(A and E) Boundary fits for the zymogen of
MASP-1 (0.28 mg/mL) and MASP-2 (0.14 mg/mL).
Each of the 60 absorbance scans were fitted. The
absorbance data are in black, whereas the
boundary fits are in red.
(B–H) The six c(s) distribution analyses are shown
for each protein, from which the peaks give the
s20,w values. The s20,w values calculated from the
crystal and initial homology structures using HY-
DROPRO are shown as dashed lines.
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When three N-glycosylation oligosaccharides were added to
the MASP structures (Figure 1), the R factors were improved
further to 4.6%–5.2% (Figures 6B, 6C, 6E, and 6F). Increasing
the number of trial models showed no further improvement in
R factors. A control Search 2 started from the best-fit scattering
models for MASP 3D and not their crystal structures and gave
unchanged R factors of 4.2%–5.8% (Figures 5B, 5C, 5E, 5F,
6B, 6C, 6E, and 6F). In summary, the ten best-fit scattering struc-
tures showed that the SP domains at the extremities of the dimer
move toward each other to create bent structures (Figures 7B,
7C, 7E, and 7F).
The extent of bend in the final full-length MASP-1 andMASP-2
models was parameterized (Figure S2B). The initial separation of
27–29 nm (MASP-1) and 24–25 nm (MASP-2) between the SP
domains in the starting models was reduced to 20–22 nm
(MASP-1) and 16–20 nm (MASP-2) in the ten best-fit models (Ta-
ble S1). While the two zymogens may be more compact than the
two activated MASPs, any difference was small. The q3 angles
between the two SP domains decreased from 166–172 in the
starting models to 100–142 (Table S1). As an independent
check of the modeling, the predicted s20,w values from the tenbest-fit models for zymogen and acti-
vated MASP-1 gave mean values of
5.92 S and 5.92 S, and those for zymogen
MASP-2 and activated MASP-2 were
5.69 S and 5.61 S. These agreed better
with the experimental s20,w value of 5.90
S, 5.79 S, 5.42 S, and 5.62 S in that order
(Table 2) than the initial predictions (see
above). In conclusion, we have demon-
strated bent and flexible MASP-1 and
MASP-2 structures in which the two SP
domains are closer together.
DISCUSSION
Our crystal structures and X-ray scat-
tering data for six rat MASPs revealed a
novel understanding of their solution
structures and in particular on their flexi-
bility. We report new experimental struc-
tures for intact full-length MASP-1 and
MASP-2 and the first identification of flex-
ible junctions between the MASP do-mains. The SAXS data were supported by ultracentrifugation
and atomistic scattering modeling, showing that the full-length
MASP solution structures are significantly bent. The EGF-
CUB2 junction appeared highly flexible with up to 90 of flex (Fig-
ure 7). The combination of these bent and flexible MASP solution
structures with our earlier model for an extended planar and flex-
ibleMBL structure (Miller et al., 2012) clarifies how theMASP and
MBL structures interact with each other to activate the lectin
pathway.
Flexibility of the MASP Domain Structures
The domain flexibility in MASPs is complementary to that
deduced previously for MBL. Evidence for MASP flexibility
comes from (1) the differences between the experimental sedi-
mentation coefficients and the predictions from the initial linear
MASP structures (Figures 4B–4D and 4F–4H) and (2) the large
deviations between the initial linear MASP structures and its
experimental X-ray scattering curve. Flexibility between CUB2
and SCR1 had previously been proposed in the formation of a
‘‘closed’’ MASP structure in which the two SCR1-SCR2-SP moi-
eties and the CUB1-EGF-CUB2 moiety were hypothesized to
form the three sides of a triangular domain arrangement thatStructure 25, 1–12, February 7, 2017 7
Figure 6. X-Ray Scattering Curve Fits for the Best-Fit MASP Dimer
Models
MASP-1 3D (A), zymogen MASP-1 (B), activated MASP-1 (C), MASP-2 3D (D),
zymogen MASP-2 (E), activated MASP-2 (F). The experimental curves I(Q) are
shown as black circles. Themodeled curves I(Q) are the colored solid lines with
their corresponding R factors in the same color. The insets show the experi-
mental (black) and modeled (color) P(r) curves. (A, D) For MASP-1 3D and
MASP-2 3D, the modeled curves for the non-glycosylated starting structures
are in blue, the glycosylated starting structures are in gray, and the best-fit
structures are in red. The dimer crystal structures for MASP-1 3D andMASP-2
3D are in blue, and the best-fit glycosylated structures are in red. (B, C, E, and
F) The modeled curves for the non-glycosylated starting structures are in blue.
The curves from the best-fit MASP models from Search 1 are red whereas
those from Search 2 are orange. The starting homology dimer models for
zymogen or activated MASP-1 or MASP-2 are in blue, and those in red are one
of the best-fit MASP dimer models from Search 1. The starting and best-fit
structures are superimposed at the CUB1-EGF domains.
Figure 5. Atomistic Modeling Analyses of the MASPs
(A–F) TheR factors of the trial models versus theirRg values are shown for each
MASP. The ten best-fit models with the lowest R factors are in red. For full-
length MASP, the best-fit models from Search 2 are in orange. The crystal
structure is shown in blue. The experimental Rg values are shown by vertical
solid lines (arrowed) with errors of ±5% shown by dashed lines. (A) MASP-1
3D, (B) zymogenMASP-1, (C) activated MASP-1, (D) MASP-2 3D, (E) zymogen
MASP-2, (F) activated MASP-2. (A, D) The 4,517 and 1,982 R factors are
compared with the calculated Rg values for theMASP 3Dmodels. (B, C, E, and
F) The 6,173–30,910 R factors are compared with the calculated Rg values for
the four MASP models.
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2003; Teillet et al., 2008). Flexibility between the EGF and
CUB2 domains was also hypothesized to be part of an activation
mechanism for the MASP-MBL complex based on a CUB2-
collagen crystal structure (Gingras et al., 2011). Differences of
up to 90 between the linear crystal structures and the bent so-
lution structures described here indicate that the EGF-CUB2
junction must be particularly flexible (Figure 7). A previous struc-
tural model for full-length MASP-1 based on a crystal structure
for the four domains of MAP-1 (Skjoedt et al., 2012) is now
seen to be too elongated and rigid when this is compared to
the views in Figure 7. MASP flexibility was not considered in
detail in a recent SAXS analysis in which 2-fold C2 symmetry
was assumed in extended MASP dimer models that were fitted
to the data (Kjaer et al., 2015). The current study has now pro-
vided clear evidence of MASP flexibility. The importance of8 Structure 25, 1–12, February 7, 2017bending relates to MASP auto-activation. The extent of bending
observed in our best-fit MASP models may permit the two SP
domains to come into contact with each other. Although this
mechanism is not clearly proven by our present analyses, it
cannot be excluded, as was suggested by another recent anal-
ysis (Kjaer et al., 2015).
In our previous SAXS structural modeling of MBL, flexibility
was deduced from a bend observed between the CRD/neck
region and the linear collagen region (Miller et al., 2012). This im-
plies that the 9–12 CRD domains found in MBL trimers and tet-
ramers are able to adjust their orientations and dock to a
mannose-coated surface, irrespectively of the roughness of
this surface. Each single CRD-mannose interaction has a low
Figure 7. The Best-Fit Solution Structures of the MASP Dimers
MASP-1 3D (A), zymogen MASP-1 (B), activated MASP-1 (C), MASP-2 3D (D),
zymogen MASP-2 (E), activated MASP-2 (F). For each protein, the ten best-fit
models were aligned based on their steric similarities to show their bent
shapes. The views to the right show views that were rotated by 90 about their
longest axes.
Figure 8. Summary View of the MBL-MASP Complex from Crystal-
lography and Scattering Analyses
Face-on (A) and side-on (B) views of the MBL-MASP complex rotated by 90.
The complex is represented as secondary structure ribbons for four collagen
helices bound toMASP-3D at the center. The collagen triple helices bind to the
Ca2+ sites of the CUB1 and CUB2 domains (Figures 2C and 2D). The flexible
regions between the CUB2 and EGF domains are arrowed in black. The MBL-
MASP complex was assembled from (1) the complex of the MASP-1 CUB2
domain with collagen (yellow; PDB: 3POB), (2) the C1s 3D complex with a
collagen-like peptide from C1q to represent the CUB1 complex (pink; PDB:
4LOR), and (3) one of the three MASP-2 3D crystal structures from this study
(cyan; PDB: 5CKN; Table 1).
Please cite this article in press as: Nan et al., Flexibility in Mannan-Binding Lectin-Associated Serine Proteases-1 and -2 Provides Insight on Lectin
Pathway Activation, Structure (2017), http://dx.doi.org/10.1016/j.str.2016.12.014affinity, with a KD of about 1 mM;multiple CRD binding increases
the affinity by several orders of magnitude.
Complexes between MASP and MBL
Recent crystal structures for the CUB1 and CUB2 domains of
C1s and MASP-2 bound to the collagen triple helices of C1q
and MBL, respectively, clarify how the MASP-MBL complexes
are formed (Gingras et al., 2011; Venkatraman Girija et al.,
2013). The superimposition of these two CUB-collagen struc-
tures with our MASP-1 and MASP-2 3D crystal structures (Fig-
ures 2A and 2B) provides a complete picture of the MASP-
MBL complex (Figure 8). The 61-Hyp-Gly-Lys-Leu-Gly-Pro-66motif within the collagen triple helix of rat MBL forms the binding
site for MASP-2 (Wallis et al., 2004). Common to both the CUB1-
collagen andCUB2-collagen interactions is Lys46 in the collagen
helices, which interacts with three of the residues that coordinate
the Ca2+ in each CUB domain. The firm identification in this study
of the three Ca2+ sites in rat MASP-2 now resolves a key ambigu-
ity of the earlier rat MASP-2 structure (Feinberg et al., 2003).
The combination of the MBL and MASP solution structures
clarify how the MBL-MASP complex is formed:
(1) Our atomistic solution structures for the MBL dimer,
trimer, and tetramer showed near-planar oligomers (Miller
et al., 2012). These possess a central hub from which the
two, three, or four monomers fan outward and were
consistent with EM and atomic force microscopy images
of human MBL oligomers (Jensenius et al., 2009), which
reported the most common angle between the MBL
collagen monomers to be 47 ± 24. This agreed well
with our values of 63 for the dimer; 36 and 6 for the
trimer; and 54, 47, and 51 for the tetramer (Miller
et al., 2012). Because the angle between the collagen he-
lices in our putative MASP-MBL complexes is about 70Structure 25, 1–12, February 7, 2017 9
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pre-formed collagen conformation that is able to interact
with MASP via two of the four potential binding sites. Sig-
nificant conformational changes of magnitude 10–20,
however, would be required for simultaneous binding to
three or four collagenous stems by the MBL trimers and
tetramers.
(2) Our flexible MASP structures revise our current under-
standing of the activation mechanism. Intra- or inter-mo-
lecular MASPmechanisms have been proposed and both
have been inferred recently (Degn et al., 2013, 2014);
however, there is no direct evidence for either mechanism
because the changes that occur when complexes bind to
a pathogen surface are not known. In the former, one-half
of dimeric rat MASP-2 binds to at least two sites in a near-
planar rat MBL structure, and MBL collagen flexibility is
reduced when the CRD domains bind to a mannose-
coated surface. This may stabilize the MASP-MBL inter-
action to trigger intra-molecular auto-activation between
the two SP domains if they move closer together (Wallis,
2007). In the latter, if the MBL collagen regions form a
‘‘bunch-of-tulips’’ structure similar to that of the hexame-
ric complement C1q structure, as often assumed (Degn
et al., 2014), a MASP dimer could bind to all four stems
within an MBL collagen cone. The SP domains in MASP
will extend outward from such an MBL cone. This binding
arrangement is supported by recent EM data of com-
plexes between human MBL tetramers and MASP-1 di-
mers (Kjaer et al., 2015). That study also favored the in-
ter-complex activation mechanism because it was
suggested that MASP-1 polypeptides are not flexible
enough to auto-activate based on SAXS and EM data.
The findings described here, using SAXS combined with
AUC and atomistic modeling, however, contradict this
observation and show that both MASPs are much more
flexible than previously thought. The observed flexibility
suggests that the SP domains could bend toward each
other within the complex to lead to intra-molecular
MASP auto-activation upon binding to amannose-coated
surface. The choice between an intra- or inter-activation
mechanism or a combination of both is presently unclear,
in particular because it is not known what happens when
MBL-MASP complexes bind to a pathogen surface.
Certainly MASP flexibility highlighted by this present
study, together with MBL flexibility, means that an intra-
molecular MASP auto-activation model cannot be
excluded.
(3) Activation does not lead to large structural changes in the
MASPs. Comparison of the zymogen and activated forms
of MASP-1 and MASP-2 reveals little difference in the
conformation or flexibility of MASP-1 or MASP-2. Instead,
changes are presumably limited to the protease domain
itself, as has been analyzed (Dobo et al., 2009; Gal
et al., 2005).Dimer Interface of the MASP Structures
A crucial issue for MASP function is the stability of the MASP
dimer in physiological buffers. Although discussed for MASPStructure 25, 1–12, February 7, 2017crystal structures (Feinberg et al., 2003; Gregory et al., 2004),
the observation of a crystallographic dimer does not prove that
this dimer exists in solution. In this context, our AUC data
showed the complete absence in solution of any monomer
peaks at concentrations of 0.8–2.2 mM for full-length MASPs
(Figure 4). These data indicate that the dimer dissociation con-
stant KD will be at least 100-fold less at around 10 nM or less.
This is consistent with MASP dimer formation at physiological
concentrations of 65–70 nM (MASP-1) and 3–5 nM (MASP-2) in
human plasma (Kjaer et al., 2015; Møller-Kristensen et al.,
2003; Terai et al., 1997). Thus, the MASP dimers are stable in
plasma. Stable dimers are characterized by a buried surface
area in excess of 800 A˚2 per molecule (Rupp, 2010). The large
buried surface areas of the dimeric 3D crystal structures (Figures
2A and 2B) totaling 880–1,200 A˚2 per molecule fully account for
the existence of stable dimers in plasma.
EXPERIMENTAL PROCEDURES
Production, Purification, and Crystallization of MASPs
All six rat MASPs and MASP fragments were produced and purified as
described (Chen and Wallis, 2001; Wallis and Dodd, 2000). Rat MASP-1 and
MASP-2 and their 3D fragments were produced in Chinese hamster ovary cells
(Supplemental Information). The zymogens were enzymatically activated. All
six proteins were purified by gel filtration chromatography on a Superdex
200 16/60 column (GE Healthcare) prior to crystallization or further analysis.
SDS-PAGE was used to check the purity of all of the samples. The MASP
3D fragments were crystallized by the sitting drop method using the buffers
specified in the Supplemental Information. X-ray diffraction data on four sets
of crystals for MASP-1 and MASP-2 3D were collected at Leicester on a
rotating copper anode source and at Diamond Light Source. Structures
were determined by molecular replacement using the crystal structures of hu-
man MASP-1 (PDB: 3DEM) and rat MASP-2 (PDB: 1NT0) as search models.
Details are provided in the Supplemental Information.
X-Ray Scattering and Analytical Ultracentrifugation
X-ray scattering curves I(Q) for MASP were acquired in two sessions on the
BioSAXS robot at Instrument BM29 at the European Synchrotron Radiation
Facility, Grenoble, France (Supplemental Information; Pernot et al., 2013;
Round et al., 2015). TheMASPs showed no radiation damage or X-ray induced
aggregation in the time frame analyses. The time-averaged runs were thus
used for data analyses to determine the radius of gyration Rg and Rxs values
fromGuinier plots and the distance distribution function P(r) curves. In AUC ex-
periments, sedimentation velocity data were obtained on Beckman XL-I instru-
ments equipped with AnTi50 rotors and using two-sector cells with column
heights of 12mmat a rotor speed of 50,000 rpm. The sedimentation coefficient
distribution c(s) analyses fitted the absorbance scans directly to the Lamm
equation, in which the sedimentation coefficient was determined from the
peak position.
Determination of Solution Structures of MASP-1 and MASP-2
Startingmodels for all theMASP solution structures were generated from crys-
tal structures. Based on earlier experience of atomistic modeling for dimers,
2-fold symmetry was not assumed for the MASP dimer modeling, and the
models sampled both symmetric and asymmetric structures. Each structural
model was subjected to two sets of conformational randomization at specified
inter-domain linkers to generate broad ranges of trial structures for assess-
ment. Likely flexible linkers between the six individual MASP domains and
the His-tag in the starting structures are identified in bold (Figure 1)—two in
the 3D proteins and five in the full-length MASPs. A dihedral angle Monte Carlo
procedure was used to generate up to 30,000 domain conformations of the six
MASPs using SASSIE (Perkins et al., 2016). Sterically overlapping poormodels
were discarded at their creation. Following this, the scattering curve simula-
tions were performed with SCT (Wright and Perkins, 2015). The output was
compared with the experimental X-ray scattering curves by using the
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Pathway Activation, Structure (2017), http://dx.doi.org/10.1016/j.str.2016.12.014calculated Guinier Rg and Rxs values and a goodness-of-fit R factor in order to
identify the best-fit solution structures (Supplemental Information). As a further
validation of the scattering modeling, sedimentation coefficients s020,w for
each glycosylated best-fit model were calculated directly from the atomic co-
ordinates using WinHydroPro v1.00, setting the radius of atomic elements as
0.284 nm in order to represent the hydrated structure (Ortega et al., 2011).
Full details are described in the Supplemental Information.
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